JenniferJohnsonMDPhD, FACP

Oncology • Philadelphia, PA

Head & Neck Cancer, Thoracic Cancer

Associate Professor

Join to view full profile

Dr. Johnson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Johnson's full profile

Already have an account?

Office
1025 walnut street
700
Philadelphia, PA 19107

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2012 - 2015
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHChief Residency, Internal Medicine, 2011 - 2012
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 2008 - 2011
University of Pittsburgh School of MedicineClass of 2008

Certifications & Licensure

PA State Medical License 2011 - 2026
DE State Medical License 2017 - 2025
NJ State Medical License 2017 - 2025
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Outstanding Teaching Fellow Thomas Jefferson University, 2012
Outstanding Teaching Resident Thomas Jefferson University, 2010
Humaneness in Medicine Philadelphia County Medical Society, 2008

Publications & Presentations

PubMed

Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer types.
Eric V Mastrolonardo, Pablo Llerena, Emma De Ravin, Kathryn Nunes, Praneet C Kaki
Cancer. 2025-03-15
Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board.
Stacy Loeb, Heather H Cheng, Channing J Paller, Emily Weg, Jennifer Johnson
Prostate Cancer and Prostatic Diseases. 2025-03-01
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.
Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena, Anastasia Nikitina, Anastasia Sobol
Clinical Cancer Research. 2025-02-03

Lectures

Safety of nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

Taproot Health Launches National Oncology Database to Advance Precision MedicineJanuary 3rd, 2020
Rakuten Medical Releases New, Post-Hoc Analysis of Safety, Pharmacokinetic (PK), Immunogenicity and Biomarker Data from Its Phase 1 & 1/2a Clinical TrialsNovember 2nd, 2019
Targeting Breast Cancer Metabolism to Fight the DiseaseNovember 28th, 2016